← All candidates
No insider filings on record.
19 filings on record.
GRIGRI Bio, Inc.
NasdaqCM · Healthcare · $4.15M
$1.90
-3.70% · Sep 15
No insider filings on record.
GRI Bio, Inc. hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 5×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what GRI ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$4.15M
Float
2.2M
100% public
Short % float
Pro
Price / profit
0.0
Price / future profit
—
Price / sales
—
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
No insider transactions on file for GRI yet.
Context
Wall St
$18.50 avg target
+873.7% vs today · 2 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.91 act+$0.29
Q1 '26−$1.61 act+$2.13
Q4 '25−$116.61 act−$87.35
Q3 '25−$35.84 act−$4.76
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice